Drugs / Cord Blood Eye Drops
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03084861 | Feb 2017 → Mar 2020 | neurotrophic keratopathy | Blood and Tissue Bank of Catalonia | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cord Blood Eye Drops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03084861 ↗ |
| Known as | CBED | “The patients were given allogeneic eye drops obtained from cord blood platelet lysate (CBED) to treat severe ocular surface lesions under a compassionate use protocol.” PMID 33085593 ↗ Oct 2020 |
| Route | Other | “Route of administration: ophthalmic/ocular” NCT03084861 ↗ |